Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lachgar

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 2, 2001
Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routesH Le Buanec, C Vetu, A Lachgar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
HIV-1-induced immune suppression may result from autoimmune disorders including anti-SLWDQ autoantibodiesJ F Zagury, J Bernard, A Achour, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1992
Critical sites: a semantic approach to protein sequences. Application to the HIV-1 envelope moleculeJ F Zagury, H Cantalloube, J Bernard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
Striking similarities between HIV-1 Env protein and the apoptosis mediating cell surface antigen Fas. Role in the pathogenesis of AIDSJ F Zagury, H Cantalloube, A Achour, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
Repair of the in vitro HIV-1-induced immunosuppression and blockade of the generation of functional suppressive CD8 cells by anti-alpha interferon and anti-Tat antibodiesA Lachgar, J Bernard, B Bizzini, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1992
Cell-mediated immunity against HGP-30, a group-specific peptide of HIV p17 in individuals infected with the AIDS virusA Willer, A Achour, J P Mbika, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDSJ F Zagury, A Lachgar, A Achour, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 3, 1999
Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic proteinH Le Buanec, A Lachgar, R D'Anna, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Tat toxoid as a component of a preventive vaccine in seronegative subjectsA Gringeri, E Santagostino, M Muça-Perja, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDSD Zagury, A Lachgar, V Chams, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 2, 2001
Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routesH Le Buanec, C Vetu, A Lachgar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
HIV-1-induced immune suppression may result from autoimmune disorders including anti-SLWDQ autoantibodiesJ F Zagury, J Bernard, A Achour, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1992
Critical sites: a semantic approach to protein sequences. Application to the HIV-1 envelope moleculeJ F Zagury, H Cantalloube, J Bernard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
Striking similarities between HIV-1 Env protein and the apoptosis mediating cell surface antigen Fas. Role in the pathogenesis of AIDSJ F Zagury, H Cantalloube, A Achour, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
Repair of the in vitro HIV-1-induced immunosuppression and blockade of the generation of functional suppressive CD8 cells by anti-alpha interferon and anti-Tat antibodiesA Lachgar, J Bernard, B Bizzini, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1992
Cell-mediated immunity against HGP-30, a group-specific peptide of HIV p17 in individuals infected with the AIDS virusA Willer, A Achour, J P Mbika, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDSJ F Zagury, A Lachgar, A Achour, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 3, 1999
Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic proteinH Le Buanec, A Lachgar, R D'Anna, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Tat toxoid as a component of a preventive vaccine in seronegative subjectsA Gringeri, E Santagostino, M Muça-Perja, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDSD Zagury, A Lachgar, V Chams, et al.
Pageof 4